J&J’s Tecvayli recommended by NICE to treat relapsed and refractory multiple myeloma
Johnson & Johnson’s (J&J) Tecvayli (teclistamab) has been recommended by the National Institute for Health and Care Excellence (NICE) to treat adults in England and Wales with relapsed and refractory multiple myeloma (RRMM). The final draft …